Related Experiment Video
Updated: Jul 19, 2025
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
A clinicopathological analysis of forkhead box A1 (FOXA1) and estrogen receptor alpha expression in extramammary
Chiho Sumitomo1, Yohei Iwata1, Masaru Arima1
1Department of Dermatology, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Objectives:
Extramammary Paget's disease (EMPD) is a neoplastic skin disease of unknown etiology. EMPD is frequently associated with forkhead box A1 (FOXA1) expression, which correlates with the expression of estrogen receptor alpha (ER). FOXA1 regulates the transcriptional activity of ER and may function cooperatively in the tumorigenesis of breast cancer.
Methods:
We performed immunohistochemical staining for FOXA1 and ER using tissue samples from 16 patients with EMPD.
Results:
The nuclei of Paget cells isolated from each of the 16 patients with EMPD (100%) were strongly FOXA1-positive, and the FOXA1 staining intensity was similar across all samples. ER staining was detected in the nuclei of Paget cells originating from seven patients with EMPD (44%), and the ER staining intensity varied between these patients.
Conclusions:
In the present study, we confirmed that EMPD was frequently associated with FOXA1 expression. However, ER expression varied between patients and did not always coincide with FOXA1 expression. No clear relationship was observed between ER expression, the intensity of ER staining, or EMPD metastasis and prognosis. However, the results indicate that hormone-dependent cancer therapy may be effective in patients with ER-positive EMPD.
